Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001763680 | SCV002001061 | uncertain significance | not provided | 2021-02-19 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Labcorp Genetics |
RCV001868565 | SCV002148154 | likely benign | Adams-Oliver syndrome 5 | 2023-11-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001868565 | SCV002553340 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002271296 | SCV002553341 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004040247 | SCV005027338 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-03-11 | criteria provided, single submitter | clinical testing | The p.P1832R variant (also known as c.5495C>G), located in coding exon 30 of the NOTCH1 gene, results from a C to G substitution at nucleotide position 5495. The proline at codon 1832 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this alteration remains unclear. |